273 related articles for article (PubMed ID: 21991950)
1. Oral acyclovir suppression and neurodevelopment after neonatal herpes.
Kimberlin DW; Whitley RJ; Wan W; Powell DA; Storch G; Ahmed A; Palmer A; Sánchez PJ; Jacobs RF; Bradley JS; Robinson JL; Shelton M; Dennehy PH; Leach C; Rathore M; Abughali N; Wright P; Frenkel LM; Brady RC; Van Dyke R; Weiner LB; Guzman-Cottrill J; McCarthy CA; Griffin J; Jester P; Parker M; Lakeman FD; Kuo H; Lee CH; Cloud GA;
N Engl J Med; 2011 Oct; 365(14):1284-92. PubMed ID: 21991950
[TBL] [Abstract][Full Text] [Related]
2. Antiviral agents for treatment of herpes simplex virus infection in neonates.
Jones CA; Walker KS; Badawi N
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD004206. PubMed ID: 19588350
[TBL] [Abstract][Full Text] [Related]
3. Oral acyclovir suppression after neonatal herpes.
Bargiela D; Lyall H; Mewasingh L
N Engl J Med; 2012 Jan; 366(1):90; author reply 90-1. PubMed ID: 22216852
[No Abstract] [Full Text] [Related]
4. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
[TBL] [Abstract][Full Text] [Related]
5. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
Kimberlin D; Powell D; Gruber W; Diaz P; Arvin A; Kumar M; Jacobs R; Van Dyke R; Burchett S; Soong SJ; Lakeman A; Whitley R
Pediatr Infect Dis J; 1996 Mar; 15(3):247-54. PubMed ID: 8852914
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Corey L; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Weller S; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
Pediatrics; 2001 Aug; 108(2):230-8. PubMed ID: 11483782
[TBL] [Abstract][Full Text] [Related]
7. Neonatal herpes simplex infection and the Three Musketeers.
Gershon AA
N Engl J Med; 2011 Oct; 365(14):1338-9. PubMed ID: 21991957
[No Abstract] [Full Text] [Related]
8. Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: Case report.
Kato K; Hara S; Kawada J; Ito Y
J Infect Chemother; 2015 Dec; 21(12):879-81. PubMed ID: 26390826
[TBL] [Abstract][Full Text] [Related]
9. Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era.
Melvin AJ; Mohan KM; Vora SB; Selke S; Sullivan E; Wald A
J Pediatric Infect Dis Soc; 2022 Mar; 11(3):94-101. PubMed ID: 34894240
[TBL] [Abstract][Full Text] [Related]
10. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series.
Pinninti SG; Angara R; Feja KN; Kimberlin DW; Leach CT; Conrad DA; McCarthy CA; Tolan RW
J Pediatr; 2012 Jul; 161(1):134-8.e1-3. PubMed ID: 22336576
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Herpes Simplex Virus: The Long Road to Improved Outcomes.
McPherson CC
Neonatal Netw; 2020 Mar; 39(2):92-98. PubMed ID: 32317339
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic management for suspected neonatal herpes simplex virus infection.
Wolfert SI; de Jong EP; Vossen AC; Zwaveling J; Te Pas AB; Walther FJ; Lopriore E
J Clin Virol; 2011 May; 51(1):8-11. PubMed ID: 21388869
[TBL] [Abstract][Full Text] [Related]
13. Management of neonatal herpes simplex virus infection.
Kesson AM
Paediatr Drugs; 2001; 3(2):81-90. PubMed ID: 11269641
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Herpes Simplex Virus: Cutaneous Recurrence Is Common on Stopping Prophylactic Suppression Therapy.
Waheed S; Nuttall L; Fidler K; Dudley J; Bamford A; Lyall H
J Pediatric Infect Dis Soc; 2022 Dec; 11(11):518-521. PubMed ID: 36048737
[TBL] [Abstract][Full Text] [Related]
15. Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.
Ericson JE; Gostelow M; Autmizguine J; Hornik CP; Clark RH; Benjamin DK; Smith PB;
Pediatr Infect Dis J; 2017 Apr; 36(4):369-373. PubMed ID: 27977557
[TBL] [Abstract][Full Text] [Related]
16. Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease.
Tiffany KF; Benjamin DK; Palasanthiran P; O'Donnell K; Gutman LT
J Perinatol; 2005 Mar; 25(3):156-61. PubMed ID: 15605069
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
Scott LL; Sanchez PJ; Jackson GL; Zeray F; Wendel GD
Obstet Gynecol; 1996 Jan; 87(1):69-73. PubMed ID: 8532270
[TBL] [Abstract][Full Text] [Related]
18. Empiric acyclovir for neonatal herpes simplex virus infection.
Vanderpluym C; Tawfik G; Hervas-Malo M; Lacaze-Masmonteil T; Kellner J; Robinson JL
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1278-82. PubMed ID: 21992471
[TBL] [Abstract][Full Text] [Related]
19. Neonatal herpes simplex virus infection: epidemiology and treatment.
James SH; Kimberlin DW
Clin Perinatol; 2015 Mar; 42(1):47-59, viii. PubMed ID: 25677996
[TBL] [Abstract][Full Text] [Related]
20. Neonatal herpes simplex virus infections.
Pinninti SG; Kimberlin DW
Semin Perinatol; 2018 Apr; 42(3):168-175. PubMed ID: 29544668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
